Last reviewed · How we verify
Naproxen sodium pills
At a glance
| Generic name | Naproxen sodium pills |
|---|---|
| Also known as | Naprosyn 250 mg tablets |
| Sponsor | Abimbola Famuyide |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Mechanistic Characterization of Uterine Pain (PHASE4)
- Trial of Naproxen Sodium for the Treatment of OCD in Children With PANDAS (PHASE4)
- Multimodal Pain Management After Wide Awake Local Anesthesia No Tourniquet Orthopedic Hand Surgery: A Randomized Control Trial (NA)
- Non Steroidal Anti-inflammatory Drugs in the Prevention of Bone Pain Flares After Palliative Radiotherapy (PHASE2)
- Inflammation and Daily Life Study (EARLY_PHASE1)
- Optimal Treatment of Acute Skeletal Muscle Injury (NA)
- Are Opioids Needed After ACL Reconstruction (PHASE4)
- Placebo In Chronic Back Pain - Double-Blind Randomized Control Trial (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Naproxen sodium pills CI brief — competitive landscape report
- Naproxen sodium pills updates RSS · CI watch RSS
- Abimbola Famuyide portfolio CI